Clinical Trial Update: A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or Advanced-Stage ENKTL. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing the P-GEMD regimen with the P-Gemox regimen in untreated early-stage or advanced extranodal NK/T-cell lymphoma, status not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma

Drugs mentioned

• P-GEMD regimen
• P-GEMOX regimen

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: NK-T-Cell Lymphoma, Extranodal | Phase 3 | Status: NOT_YET_RECRUITING